Total Payments
$2,148
2024 Payments
$657.39
Companies
27
Transactions
89
Medicare Patients
2,006
Medicare Billing
$283,061
Payment Breakdown by Category
Food & Beverage$2,106 (98.0%)
Education$42.00 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,106 | 87 | 98.0% |
| Education | $42.00 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $336.00 | 12 | $0 (2024) |
| Travere Therapeutics, Inc. | $328.31 | 11 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $204.49 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $153.50 | 6 | $0 (2024) |
| Amgen Inc. | $148.04 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $107.07 | 5 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $96.29 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90.77 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $68.27 | 3 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $66.72 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $657.39 | 29 | Novartis Pharmaceuticals Corporation ($90.77) |
| 2023 | $452.34 | 21 | Travere Therapeutics, Inc. ($86.56) |
| 2022 | $603.44 | 28 | AstraZeneca Pharmaceuticals LP ($99.79) |
| 2021 | $408.53 | 9 | AstraZeneca Pharmaceuticals LP ($143.41) |
| 2019 | $26.61 | 2 | AKEBIA THERAPEUTICS INC ($26.61) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.44 | General |
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Endovascular | ||||||
| 09/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.06 | General |
| 09/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.39 | General |
| 08/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Nephrology | ||||||
| 07/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Rare Disease | ||||||
| 07/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Nephrology | ||||||
| 07/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Rare Disease | ||||||
| 06/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.89 | General |
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Cardio-renal | ||||||
| 06/10/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: OSTEOPOROSIS | ||||||
| 06/04/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Hyperkalemia | ||||||
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: NEPHROLOGY | ||||||
| 05/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Nephrology | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 03/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.05 | General |
| 02/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.51 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 980 | 1,477 | $336,340 | $136,242 |
| 2022 | 9 | 814 | 1,266 | $318,163 | $119,326 |
| 2021 | 7 | 212 | 296 | $79,323 | $27,493 |
Total Patients
2,006
Total Services
3,039
Medicare Billing
$283,061
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 195 | 436 | $99,844 | $43,728 | 43.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 179 | 191 | $81,748 | $28,160 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 164 | 280 | $44,800 | $18,564 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 141 | 223 | $34,619 | $17,456 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 74 | 74 | $18,454 | $7,447 | 40.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 56 | $16,408 | $6,114 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 58 | $8,999 | $4,535 | 50.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 38 | 58 | $15,950 | $3,461 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 23 | $6,312 | $2,676 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 26 | $2,075 | $1,214 | 58.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 24 | $2,232 | $1,019 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,706 | $938.20 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $2,193 | $929.43 | 42.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 213 | 489 | $111,981 | $41,956 | 37.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 148 | 156 | $68,766 | $25,938 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 142 | 255 | $40,800 | $15,363 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 77 | 77 | $19,170 | $8,769 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 82 | $11,436 | $6,708 | 58.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 32 | 32 | $10,688 | $4,888 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 29 | 32 | $7,341 | $3,762 | 51.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $9,933 | $3,760 | 37.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 37 | 58 | $28,514 | $3,585 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,514 | $2,440 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 30 | $4,020 | $2,157 | 53.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 84 | $19,236 | $7,348 | 38.2% |
About Dr. Nevin Murthy, MD
Dr. Nevin Murthy, MD is a Nephrology healthcare provider based in Gurnee, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1093100240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nevin Murthy, MD has received a total of $2,148 in payments from pharmaceutical and medical device companies, with $657.39 received in 2024. These payments were reported across 89 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,106).
As a Medicare-enrolled provider, Murthy has provided services to 2,006 Medicare beneficiaries, totaling 3,039 services with total Medicare billing of $283,061. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Gurnee, IL
- Active Since 04/04/2015
- Last Updated 08/23/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1093100240
Products in Payments
- LOKELMA (Drug) $165.78
- Thiola (Drug) $150.73
- ACTHAR (Biological) $121.72
- JYNARQUE (Drug) $107.07
- FARXIGA (Drug) $105.67
- PURIFIED CORTROPHIN GEL (Drug) $100.99
- TARPEYO (Drug) $96.29
- ULTOMIRIS (Biological) $88.06
- TAVNEOS (Drug) $78.58
- Kerendia (Drug) $68.27
- RAYALDEE (Drug) $66.72
- STRENSIQ (Biological) $62.40
- Ultomiris (Drug) $54.03
- KRYSTEXXA (Biological) $48.89
- Aranesp (Biological) $48.38
- Crysvita (Drug) $44.53
- Veltassa (Drug) $34.72
- TERLIVAZ (Drug) $31.78
- AURYXIA (Drug) $26.61
- TERIPARATIDE (Drug) $23.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Gurnee
Dr. Omaima Degani, M.d, M.D
Nephrology — Payments: $137,904
Nephrology $137,904
Dr. Rakhi Khanna, D.o, D.O
Nephrology — Payments: $37,820
Nephrology $37,820
Dr. Leon Sujata, Md, MD
Nephrology — Payments: $20,230
Nephrology $20,230
Nino Alapishvili
Nephrology — Payments: $6,032
Nephrology $6,032
Dr. Salima Din, Md, MD
Nephrology — Payments: $1,309
Nephrology $1,309
Walid Ghantous, M.d, M.D
Nephrology — Payments: $14.63
Nephrology $14.63